Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17) - Image 1

£78.10

Springer Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Name: Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
Brand: Springer
Price: 89.78 GBP
Availability: InStock

General Medical Issues

Price History & Forecast

Last 36 days • 36 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 36 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £90 (20 days, 55.6%)

Price range: £78 - £90

Price levels: 4 different prices over 36 days

Description

In the last decade, the literature on molecular mechanisms and activated pathways in the different lymphoma categories increased exponentially, which was followed by a more diffuse and successful use of targeted therapies. In this book, expert authors revisit the most relevant aspects of these therapies, with special emphasis on molecular mechanisms and clinical effects of resistance. The knowledge of the underlying mechanisms involved in tumor resistance to target therapies is of paramount importance because they will result in a better selection of patients with sensitive disease and the establishment of suitable combinations of drugs that target different molecules and could overcome the established resistance.

Product Specifications

Brand: Springer
Format: Hardcover
ASIN: 3319751832
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues
Domain: Amazon UK
Release Date: 13 April 2018
Listed Since: 09 January 2018

Barcode

No barcode data available

Springer Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)

Springer - Molecular Mechanisms of Tumor Cell Resistance

Molecular Targets in Cancer Therapy: Understanding Cellular Pathways for Therapeutic Interventions

Aggressive Lymphomas (Hematologic Malignancies)

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)

Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)

Targeted Therapies for Lung Cancer (Current Cancer Research)

Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer Hodgkin's and Non-Hodgkin's Lymphoma - Research Book

Springer - Therapeutic Resistance to Anti-hormonal Drugs Book

Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy

Multiple Drug Resistance in Cancer 2: Molecular, Cellular and Clinical Aspects

Multiple Drug Resistance in Cancer 2: Molecular, Cellular and Clinical Aspects

Springer - Resistance to Immunotherapeutic Antibodies in Cancer

Springer - Lung Cancer: Treatment and Research: 170 Book

Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)

Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)

Lung Cancer: Treatment and Research: 170

Springer - Stress Response Pathways in Cancer Textbook

Rare Lymphomas (Hematologic Malignancies)

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal